Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy

Brief description of study

The purpose of this research study is to identify factors that can predict how patients with idiopathic generalized epilepsy will do on a given seizure medication, whether they will have side effects, and whether they will have more seizures. These factors are called biomarkers. Biomarkers are an indicator of a disease or pathology.

Clinical Study Identifier: s19-01030 Identifier: NCT05374928
Principal Investigator: Christopher Elder.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.